Namita Thapar-backed Emcure Pharma IPO opens: GMP, price, apply or not? | News on Markets
The Namita Thapar-backed Emcure Pharma IPO has opened for subscription with a price band of Rs 594-600 per share. The ...
The Namita Thapar-backed Emcure Pharma IPO has opened for subscription with a price band of Rs 594-600 per share. The ...
The Indian pharmaceutical industry has been granted approval to produce peptide diabetes drugs under the Production Linked Incentive (PLI) scheme. ...
Swiss startup SkyCell has secured an additional $59 million in funding for its eco-friendly smart pharmaceutical transport containers. The containers ...
The weight loss drug from Zealand Pharma has seen a significant 23% jump in its stock value following positive trial ...
Copyright © 2026 News Wave
News Wave is not responsible for the content of external sites.